edronax
pfizer pfe pharmaceuticals israel ltd - reboxetine methan sulfonate - tablets - reboxetine methan sulfonate 4 mg - reboxetine - reboxetine - reboxetine is indicated for the acute treatment of depressive illness/major depression and for maintaining the clinical improvement in patients initially responding to treatment.
reboxetine tablets 2 milligram
pharmacia ireland - reboxetine mesylate - tablets - 2 milligram
reboxetine tablets 4 milligram
pharmacia ireland - reboxetine mesylate - tablets - 4 milligram
edronax
pfizer new zealand limited - reboxetine mesilate 2.612mg equivalent to 2 mg reboxetine free base - tablet - 2 mg - active: reboxetine mesilate 2.612mg equivalent to 2 mg reboxetine free base excipient: calcium hydrogen phosphate dihydrate crospovidone hydrated silica magnesium stearate powdered cellulose - reboxetine is indicated for the treatment of depressive illness and for maintaining the clinical improvement in patients initially responding to treatment. the remission of the acute phase of the depressive illness is associated with an improvement in the patient's quality of life in terms of social adaptation.
edronax reboxetine 4mg (as mesilate) tablet blister pack
pfizer australia pty ltd - reboxetine mesilate, quantity: 5.224 mg (equivalent: reboxetine, qty 4 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; magnesium stearate; silicon dioxide - indications: edronax is indicated for the treatment of major depression and is effective in preventing the relapse of depressive symptoms.
reboxetine 4mg tablets
imported - reboxetine mesilate - oral tablet - 4mg
edronax
pfizer new zealand limited - reboxetine mesilate 5.224mg equivalent to 4 mg reboxetine free base - tablet - 4 mg - active: reboxetine mesilate 5.224mg equivalent to 4 mg reboxetine free base excipient: calcium hydrogen phosphate dihydrate crospovidone hydrated silica magnesium stearate powdered cellulose
edronax 4 mg tablets
pfizer healthcare ireland - reboxetine - tablet - 4 milligram(s) - other antidepressants; reboxetine
edronax 4 mg tabl.
pfizer sa-nv - reboxetine mesilate 5,22 mg - eq. reboxetine 4 mg - tablet - 4 mg - reboxetine mesilate 5.22 mg - reboxetine
edronax 4mg tablets
pfizer ltd - reboxetine mesilate - oral tablet - 4mg